Editorial Board
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Surgery, Duke University Medical Center, Duke Cancer Institute, Durham, NC 27710, USA
Interests: programmed cell death signaling; multiscale modeling; tumor microenvironment; human environmental health; cancer and exposure science; inflammatory breast cancer
Interests: programmed cell death signaling; multiscale modeling; tumor microenvironment; human environmental health; cancer and exposure science; inflammatory breast cancer
Stephenson Cancer Center, Oklahoma University Health Science Center, Oklahoma, OK 73104, USA
Interests: cancer; cell signaling; oncogenes; non-coding RNAs; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; cell signaling; oncogenes; non-coding RNAs; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
1. School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute (CHIRI), Curtin University, Perth, WA, Australia
2. School of Human Sciences, The University of Western Australia, Nedlands, Perth, WA 6009, Australia
3. Trichy SRM Medical College Hospital and Research Centre, SRM Nagar, Trichy—Chennai Highways, Irungalur, Trichy 621 105, India
Interests: wnt signaling; secreted frizzled related protein 4; cancer; cancer stem cells; angiogenesis; apoptosis; redox signaling; molecular modeling
Special Issues, Collections and Topics in MDPI journals
2. School of Human Sciences, The University of Western Australia, Nedlands, Perth, WA 6009, Australia
3. Trichy SRM Medical College Hospital and Research Centre, SRM Nagar, Trichy—Chennai Highways, Irungalur, Trichy 621 105, India
Interests: wnt signaling; secreted frizzled related protein 4; cancer; cancer stem cells; angiogenesis; apoptosis; redox signaling; molecular modeling
Special Issues, Collections and Topics in MDPI journals
Department of Medicine, Surgery and Neurosciences, University of Siena, Via Banchi di Sotto, 55, 53100 Siena, Italy
Interests: skin cancer; brain tumors and epigenetics
Interests: skin cancer; brain tumors and epigenetics
1. Medical oncology, AOU University Federico II, 80131 Napoli, Italy
2. Department of Medicine, University of Molise, 86100 Campobasso, Italy
Interests: prostate cancer; bladder cancer; kidney cancer; penile cancer; testicular cancer; genito-urinary cancers; chemotherapy; prognostic factors; biological agents; randomized trials
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine, University of Molise, 86100 Campobasso, Italy
Interests: prostate cancer; bladder cancer; kidney cancer; penile cancer; testicular cancer; genito-urinary cancers; chemotherapy; prognostic factors; biological agents; randomized trials
Special Issues, Collections and Topics in MDPI journals
Department of Oncology, University of Torino, 10043 Orbassano, Italy
Interests: colorectal cancer; target therapies; liquid biopsy; cancer biomarkers; BRAF
Interests: colorectal cancer; target therapies; liquid biopsy; cancer biomarkers; BRAF
Institut de Recherche sur la Santé, l’Environnement et le Travail (IRSET), INSERM UMR 1085, F-35043 Rennes, France
Interests: apoptosis/necroptosis; RIP1; TRAIL; hepatocarcinoma; hepatitis
Interests: apoptosis/necroptosis; RIP1; TRAIL; hepatocarcinoma; hepatitis
Department of Pharmacology, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece
Interests: cancer; animal models of cancer; new p90 ribosomal S6 kinase inhibitors; plant derivatives; anticancer drug development
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; animal models of cancer; new p90 ribosomal S6 kinase inhibitors; plant derivatives; anticancer drug development
Special Issues, Collections and Topics in MDPI journals
Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, 80 Vas. Sofias Ave, 11528 Athens, Greece
Interests: multiple myeloma; Waldenstrom’s macroglobulinemia; amyloidosis; lymphomas; oncology
Interests: multiple myeloma; Waldenstrom’s macroglobulinemia; amyloidosis; lymphomas; oncology
Department of Pathology and O’Neal Comprehensive Cancer Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294-3300, USA
Interests: molecular basis of cancer metabolic reprogramming; molecular control of the amino acid deprivation response; MYCN oncogene; neuroblastoma
Interests: molecular basis of cancer metabolic reprogramming; molecular control of the amino acid deprivation response; MYCN oncogene; neuroblastoma
Department of Life Sciences, Neuroscience Solutions to Cancer Research Group, Imperial College London, Sir Alexander Fleming Building, South Kensington Campus, London SW7 2AZ, UK
Interests: metastasis; epigenetics; ion channels; pH; diet; nutraceuticals; growth factors; bioelectricity
Special Issues, Collections and Topics in MDPI journals
Interests: metastasis; epigenetics; ion channels; pH; diet; nutraceuticals; growth factors; bioelectricity
Special Issues, Collections and Topics in MDPI journals
Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy
Interests: gliomagenesis; adenocarcinoma
Interests: gliomagenesis; adenocarcinoma
Department of Biochemistry, Faculty of Medicine, Health Research Institute Alberto Sols CSIC-UAM, IdiPaz, 28029 Madrid, Spain
Interests: biomedicine; molecular; cellular and genetic biology
Interests: biomedicine; molecular; cellular and genetic biology
Prof. Dr. Matteo Donadon
Editorial Board Member
University Maggiore Hospital, University of Piemonte Orientale, 28100 Novara, Italy
Interests: liver; laparoscopic surgery; intraoperative US of liver
Special Issues, Collections and Topics in MDPI journals
Interests: liver; laparoscopic surgery; intraoperative US of liver
Special Issues, Collections and Topics in MDPI journals
Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Hokkaido University, Sapporo 060-8638, Japan
Interests: cancer biomarkers; epigenetics; non-coding RNAs (miRNA, long non-coding RNA, and circular RNA); metastasis; chemoresistance; meta-analysis; bioinformatics; anti-cancer drug; cancer cell signaling
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biomarkers; epigenetics; non-coding RNAs (miRNA, long non-coding RNA, and circular RNA); metastasis; chemoresistance; meta-analysis; bioinformatics; anti-cancer drug; cancer cell signaling
Special Issues, Collections and Topics in MDPI journals
National Center for Cancer Immuno Therapy, CCIT-DK, Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark
Interests: Cancer Immunotherapy; T cell therapy; Melanoma
Interests: Cancer Immunotherapy; T cell therapy; Melanoma
1. Capital Health Medical Center, Pennington, NJ 08534, USA
2. Department of Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19122, USA
3. Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA
Interests: artificial intelligence applied to cancer care; the latest diagnostic and treatment options in cancer
2. Department of Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19122, USA
3. Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA
Interests: artificial intelligence applied to cancer care; the latest diagnostic and treatment options in cancer
Department of Urology, Sheba Tel HaShomer Hospital, Tel-Aviv University, 6997801 Tel Aviv-Yafo, Israel
Interests: surgical oncology in urology; prostate cancer; kidney cancer; bladder cancer; testis cancer
Interests: surgical oncology in urology; prostate cancer; kidney cancer; bladder cancer; testis cancer
Department of Medicine, Hematology Oncology Division, MUSC, 96 Jonathan Lucas St., Charleston, SC 29425, USA
Interests: Kidney cancer; lung cancer; acute myelogenous leukemia (AML); Cholesterol and cancer; Neuropilin 1; Neuropilin 2; Semaphorins; TRC8 (RNF139); VHL; EZH2; EMT (epithelial-mesenchymal transition); ZEB1
Interests: Kidney cancer; lung cancer; acute myelogenous leukemia (AML); Cholesterol and cancer; Neuropilin 1; Neuropilin 2; Semaphorins; TRC8 (RNF139); VHL; EZH2; EMT (epithelial-mesenchymal transition); ZEB1
Department of Hematology, School of Medicine, University of Ioannina, 451 10 Ioannina, Greece
Interests: biostatistics; clinical trial design; real world evidence generation; health economics; health technology assessment
Interests: biostatistics; clinical trial design; real world evidence generation; health economics; health technology assessment
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
Interests: ovarian cancer; cancer genetics; cancer biology; molecular pathology; mouse models; anatomic pathology
Interests: ovarian cancer; cancer genetics; cancer biology; molecular pathology; mouse models; anatomic pathology
Department of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, QC J1H 5H3, Canada
Interests: metabolic tumor microenvironment; hypoxia; LPA/autotaxin; invadopodia; cell invasion; metastasis; chicken chorioallantoic membrane (CAM)-based PDX model; personalized medicine
Interests: metabolic tumor microenvironment; hypoxia; LPA/autotaxin; invadopodia; cell invasion; metastasis; chicken chorioallantoic membrane (CAM)-based PDX model; personalized medicine
Department of Radiation Oncology (MaastRO Lab), GROW–School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
Interests: hypoxia targeting; preclinical research; oncology; non-invasive imaging; immunotherapy
Interests: hypoxia targeting; preclinical research; oncology; non-invasive imaging; immunotherapy
1. OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, German Cancer Research Center (DKFZ), Heidelberg, Germany
2. German Cancer Consortium (DKTK), Partner Site Dresden, Germany, 01309 Dresden, Germany
Interests: biomarkers for the individualized radiotherapy; metabolic biomarkers for cancers; cancer stem cells; molecular mechanisms of cancer radioresistance; therapy-induced tumor reprogramming; tumor radiosensitization
Special Issues, Collections and Topics in MDPI journals
2. German Cancer Consortium (DKTK), Partner Site Dresden, Germany, 01309 Dresden, Germany
Interests: biomarkers for the individualized radiotherapy; metabolic biomarkers for cancers; cancer stem cells; molecular mechanisms of cancer radioresistance; therapy-induced tumor reprogramming; tumor radiosensitization
Special Issues, Collections and Topics in MDPI journals
Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA
Interests: liver cancer; metastatic tumor; combination therapies; angiogenesis inhibitors; biomarker studies; cancer immunotherapy; carcinoma hepatocellular; carcinoma pancreatic ductal; metastasis; translational research and clinical trials; tumor microenvironment
Interests: liver cancer; metastatic tumor; combination therapies; angiogenesis inhibitors; biomarker studies; cancer immunotherapy; carcinoma hepatocellular; carcinoma pancreatic ductal; metastasis; translational research and clinical trials; tumor microenvironment
Institut de Recherche Saint Louis (IRSL), Université de Paris, F-75010 Paris, France
Interests: melanoma; signal transduction; targeted therapies; drug resistance; MAPK; PI3K; cAMP
Special Issues, Collections and Topics in MDPI journals
Interests: melanoma; signal transduction; targeted therapies; drug resistance; MAPK; PI3K; cAMP
Special Issues, Collections and Topics in MDPI journals
Institute for Anatomy II, Department of Neuroanatomy, University of Duisburg-Essen, University Medicine Essen, 45122 Essen, Germany
Interests: genes and miRNAs involved in retinoblastoma etiology and progression; mechanisms underlying RB chemoresistance; adjuvant RB treatment strategies; nanoparticle-mediated treatment approaches; role of trefoil factor family (TFF) peptides in RB; CAM assay as in vivo pre-screening model
Special Issues, Collections and Topics in MDPI journals
Interests: genes and miRNAs involved in retinoblastoma etiology and progression; mechanisms underlying RB chemoresistance; adjuvant RB treatment strategies; nanoparticle-mediated treatment approaches; role of trefoil factor family (TFF) peptides in RB; CAM assay as in vivo pre-screening model
Special Issues, Collections and Topics in MDPI journals
Division of Cancer and Genetics, Cardiff University, Cardiff, UK
Interests: mTOR; tuberous sclerosis complex; autophagy; cancer; cell signalling; tumour microenvironment; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
Interests: mTOR; tuberous sclerosis complex; autophagy; cancer; cell signalling; tumour microenvironment; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals
CHU de Québec-Université Laval Research Center, Quebec City, QC G1S 4L8, Canada
Interests: breast cancer; inherited breast cancer; biomarkers; personalized treatment; -omics
Interests: breast cancer; inherited breast cancer; biomarkers; personalized treatment; -omics
Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA
Interests: antibody-drug conjugate; EGFR pathway; KRAS mutated NSCLC; acquired treatment resistance; small cell lung cancer; cancer vaccine; immune checkpoint inhibition
Interests: antibody-drug conjugate; EGFR pathway; KRAS mutated NSCLC; acquired treatment resistance; small cell lung cancer; cancer vaccine; immune checkpoint inhibition
